The Globo G1 fact-check team said that claims describing the dengue vaccine as an experiment on the Brazilian population are false [1].

This debunking is critical as misinformation regarding vaccine safety and administration can undermine public trust in health initiatives. In regions where dengue is endemic, vaccine hesitancy may lead to higher infection rates and a greater burden on the healthcare system.

According to the investigation, reports circulated suggesting that the vaccine was administered as a trial using the general population as "guinea pigs" [1]. The fact-check team said these assertions were without merit, noting that the administration of the vaccine followed established public health protocols [1].

Health authorities said that the vaccine, known as Dengvaxia, was not applied as an experimental test on the public [2]. Instead, the rollout adhered to approved medical, and regulatory standards meant to ensure safety and efficacy [2].

While the misinformation gained traction online, the verified data shows that the process remained within the bounds of standard clinical and public health operations [1]. The investigation said that the vaccine's distribution was a planned health measure rather than an unregulated trial [2].

This effort to correct the record comes after the claims surfaced in 2024 [2]. The Globo team utilized available health data and official statements to clarify the nature of the immunization campaign, highlighting the difference between approved public health rollouts and experimental trials [1].

Claims describing the dengue vaccine as an experiment on the Brazilian population are false.

The persistence of 'guinea pig' narratives suggests a recurring challenge in public health communication, where the transition from clinical trials to mass administration is often misinterpreted by the public. By debunking these claims, health authorities aim to stabilize vaccine confidence in Brazil, ensuring that the population relies on regulatory approvals rather than social media rumors during endemic outbreaks.